ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Jarle Vaage
Guro Valen
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vaage, J.
Right arrow Articles by Valen, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vaage, J.
Right arrow Articles by Valen, G.
Related Collections
Right arrow Myocardial infarction

Ann Thorac Surg 2003;75:S709-S714
© 2003 The Society of Thoracic Surgeons

II: Surgical myocardial protection

Preconditioning and cardiac surgery

Jarle Vaage, MD, PhDa*, Guro Valen, MD, PhDb

a Department of Thoracic Surgery, Karolinska Hospital, Stockholm, Sweden,
b Crafoord Laboratory for Experimental Surgery, Karolinska Hospital, Stockholm, Sweden

* Address reprint requests to Dr Vaage, Department of Thoracic Surgery, Karolinska Hospital, 17176 Stockholm, Sweden.
e-mail: jarle.vaage{at}ks.se

Presented at the 3rd International Symposium on Myocardial Protection From Surgical Ischemic-Reperfusion Injury, Asheville, NC, June 2–6, 2002.

Abstract

Preconditioning is in experimental studies the most powerful mode of cardioprotection known. The signal transduction pathways involve a variety of trigger substances, mediators, receptors, and effectors. The studies of preconditioning in cardiac surgery provide conflicting results but the majority of studies show that ischemic preconditiong is an effective adjunct to myocardial protection. However, ischemic preconditioning with repeated clamping of the aorta will never get widespread use. If the "preconditioning reponse" is to be exploited in cardiac surgery, targeting the underlying molecular mechanisms must provide easily applicable techniques or drugs, which are shown in large scale clinical studies to be beneficial.




This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
R. A. Kloner and S. H. Rezkalla
Preconditioning, postconditioning and their application to clinical cardiology
Cardiovasc Res, May 1, 2006; 70(2): 297 - 307.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
C.-H. Huang, J.-S. Wang, S.-C. Chiang, Y.-Y. Wang, S.-T. Lai, and Z.-C. Weng
Brief pressure overload of the left ventricle preconditions rabbit myocardium against infarction
Ann. Thorac. Surg., August 1, 2004; 78(2): 628 - 633.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
M. Galagudza, D. Kurapeev, S. Minasian, G. Valen, and J. Vaage
Ischemic postconditioning: brief ischemia during reperfusion converts persistent ventricular fibrillation into regular rhythm
Eur. J. Cardiothorac. Surg., June 1, 2004; 25(6): 1006 - 1010.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 by The Society of Thoracic Surgeons.